Bionoid Pharma Inc
AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. an… Read more
Market Cap & Net Worth: Bionoid Pharma Inc (BINP)
Bionoid Pharma Inc (PINK:BINP) has a market capitalization of $2.70 Million ($2.70 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48954 globally and #15015 in its home market, demonstrating a 25.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bionoid Pharma Inc's stock price $0.05 by its total outstanding shares 53994610 (53.99 Million).
Bionoid Pharma Inc Market Cap History: 2015 to 2025
Bionoid Pharma Inc's market capitalization history from 2015 to 2025. Data shows change from $1.08 Billion to $2.70 Million (-48.17% CAGR).
Bionoid Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bionoid Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1439.63x
Bionoid Pharma Inc's market cap is 1439.63 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
4605.08x
Bionoid Pharma Inc's market cap is 4605.08 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $350.96 Million | $56.17K | $27.15K | 6248.04x | 12927.84x |
| 2020 | $310.47 Million | $30.66K | -$455.78K | 10127.18x | N/A |
| 2021 | $19.98 Million | $102.12K | -$135.00K | 195.63x | N/A |
| 2022 | $67.49 Million | $36.04K | $1.48K | 1872.68x | 45665.27x |
| 2023 | $53.99 Million | $37.51K | $11.72K | 1439.63x | 4605.08x |
Competitor Companies of BINP by Market Capitalization
Companies near Bionoid Pharma Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Bionoid Pharma Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Bionoid Pharma Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Bionoid Pharma Inc's market cap moved from $1.08 Billion to $ 2.70 Million, with a yearly change of -48.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.70 Million | -78.26% |
| 2024 | $12.42 Million | -77.00% |
| 2023 | $53.99 Million | -20.00% |
| 2022 | $67.49 Million | +237.84% |
| 2021 | $19.98 Million | -93.57% |
| 2020 | $310.47 Million | -11.54% |
| 2019 | $350.96 Million | -48.00% |
| 2018 | $674.93 Million | +56.25% |
| 2017 | $431.96 Million | -20.00% |
| 2016 | $539.95 Million | -50.00% |
| 2015 | $1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bionoid Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.70 Million USD |
| MoneyControl | $2.70 Million USD |
| MarketWatch | $2.70 Million USD |
| marketcap.company | $2.70 Million USD |
| Reuters | $2.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.